author-photo

Anusha Vallurupalli

University of Kansas

13

Papers

22

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

A phase 1/2 study of the combination of acalabrutinib and vistusertib in patients with relapsed/refractory B-cell malignancies.

2021 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (0)
Mosunetuzumab, a Novel CD20/CD3 Bispecific Antibody, in Combination with CHOP Confers High Response Rates in Patients with Diffuse Large B-Cell Lymphoma

2020 Blood
Show All
- Source
- Cite
- Save
Citations (10)
Functional cooperativity of p97 and histone deacetylase 6 in mediating DNA repair in mantle cell lymphoma cells

2019 Leukemia
Show All
- Source
- Cite
- Save
Citations (8)
A phase Ib/II study of oral nanatinostat (N) and valganciclovir (VG) in subjects with Epstein-Barr virus (EBV)-associated lymphomas.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Combination of Oral Nanatinostat (Nstat), a Novel Histone Deacetylase Inhibitor (HDACi), and the Oral Anti-Viral, Valganciclovir (VGCV), Is Active in Relapsed/Refractory (R/R) Epstein-Barr Virus (EBV)-Positive B-Cell, T-Cell, and Hodgkin Lymphoma: Interim Safety and Efficacy Results from a Phase 1b/2a Study

2019 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Fractionated Dosing of CLR 131 in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)

2019 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Abstract 1058: Synergistic activity of p97 inhibitors with histone deacetylase 6 inhibitors in mantle cell lymphoma

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)